Clinical Trial Update: Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of mepolizumab as adjunctive therapy in adults with severe uncontrolled refractory asthma; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2016-01-26